Clinical Trial

Cryobiopsy Vs. Forceps Biopsy for Peripheral Pulmonary Lesions

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated January 3, 2025 (before its estimated November 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This multicenter clinical trial evaluates the diagnostic yields of cryobiopsy and forceps biopsy for peripheral lung nodules. In the cryobiopsy group, cryobiopsy is the primary method, supplemented by forceps biopsy. Conversely, in the forceps biopsy group, forceps biopsy is the primary method, supplemented by cryobiopsy. The study also explores the complementary relationship between the two methods and examines differences in diagnostic rates based on the order in which the procedures are performed.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-21.
Trial Details
NCT Number NCT06752395
Lead Sponsor Pusan National University Hospital
Collaborators: Erbe-med
Conditions Lung Cancer (NSCLC)
Enrollment 200 participants
Start Date 2024-11-01
Primary Completion 2025-11-01 (estimated)
Study Completion 2026-11-01 (estimated)
Updated on ClinicalTrials.gov 2025-01-03